Stifel raises Mondelez stock price target to $74 on strong Q3 results

Mondelez reported Q3 adjusted EPS of $0.78, beating the $0.71 analyst estimate, while revenue of $9.97 billion narrowly missed the $9.98 billion forecast and organic sales growth was 2.1%, in line with projections. Volume and mix growth accelerated to 1.8%, gross margin expanded 380 basis points, and Stifel raised its price target to $74 from $68 while keeping a Buy rating. Mondelez reiterated its fiscal 2026 outlook and maintained expectations for strong 2027 earnings growth; Stifel raised its 2026 and 2027 EPS estimates to $3.05 and $3.36.

Analysis

The earnings beat looks more like a margin-and-execution win than evidence of a broad demand re-acceleration. That distinction matters: volume recovery and share retention can support durable earnings, but recent gross-margin leverage from lower cocoa costs is a less dependable engine and could reverse as input costs reset. Management’s decision to reinvest upside limits near-term earnings carry-through while potentially protecting brand health and volume into 2027.

The key test over the next 1–3 months is whether volume/mix holds up after incremental consumer spending, rather than whether another cost-driven beat is delivered. A weak sales trend alongside resilient EPS would argue that estimates are becoming too dependent on productivity and commodity relief. Over 6–18 months, sustained volume growth would improve pricing flexibility and help defend against competitors such as Hershey and Nestlé; renewed cocoa inflation would pressure chocolate-heavy categories and narrow the margin buffer.

With the shares near their recent high after a strong year-to-date move, positive analyst revisions may be partly reflected in price. The contrarian risk is that investors extrapolate one quarter’s margin expansion, while the more durable signal—volume and share gains—still needs confirmation. No evidence here establishes the persistence of cocoa-cost relief or the scale of reinvestment returns.

Key Decisions for Investors

• Do not chase the initial earnings reaction. Consider a staged MDLZ long on a pullback, or after a sustained breakout above the reported 52-week high, only if subsequent updates confirm positive volume/mix; size the position around commodity-reversal risk.
• Track cocoa input-cost trends, quarterly volume/mix, market-share breadth, and gross-margin guidance. Treat volume deterioration or margin guidance that relies on continued commodity relief as a thesis warning.
• Falsify the constructive view if volume/mix turns negative, share gains narrow materially, or management reduces its 2027 growth outlook. In that case, avoid adding and reassess exposure rather than treating another EPS beat as sufficient evidence.
• Relative-value watch: compare MDLZ’s volume and margin trajectory with Hershey and Nestlé before considering a pair trade; the supplied information is insufficient to justify a short leg or claim that either competitor is mispriced.